Vaccines designed to safeguard patients from HIV can
backfire and lead to increased rates of infection. This negative effect has
been seen in more than one vaccine clinical trial.
Scientists at the Yerkes National Primate Research Center,
Emory University, have newly published results that support a straightforward
explanation for the backfire effect. According to the study, the vaccination
may increase the number of immune cells that serve as viral targets.
AIDS-HIV-Cancer
AIDS defining malignancies are cancers that occur in patients with AIDS due to their low immunity.
Advertisement
In a nonhuman primate model of HIV transmission, higher levels of viral target cells in gateway mucosal tissues were associated with an increased risk of infection.
The findings suggest that vaccine researchers, when
evaluating potential HIV/AIDS vaccines, may need to steer away from those that
activate too many viral target cells in mucosal tissues.
![AIDS / HIV - Treatment]( "AIDS / HIV - Treatment")
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
"One of the reasons why it has been so difficult to make an AIDS vaccine is that the virus infects the very cells of the immune system that any vaccine is supposed to induce," says senior author Guido Silvestri, chief of microbiology and immunology at Yerkes National Primate Research Center.
A large part of the vaccine effort has been focused on developing vaccines that stimulate antiviral T cells.
T cells come in two main categories, defined by the molecules found on their surfaces.
CD8 is a marker for "killer" cells, while CD4 is a marker for "helper" cells. CD4+ T cells are known to be primary targets for HIV and SIV infection, while several studies have proposed that CD8+ T cells could be valuable in controlling infection.
"This study shows that if a vaccine induces high levels of activated CD4+ T cells in mucosal tissues, any potential protective effect of the vaccine may be hampered," he explains.
The study emphasizes the unique challenges that HIV poses in terms of vaccine development, and the importance of pursuing vaccine concepts and products that elicit strong antiviral immune responses without increasing the number of CD4+ T cells in the
Source: Medindia
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
Advertisement
"One of the reasons why it has been so difficult to make an AIDS vaccine is that the virus infects the very cells of the immune system that any vaccine is supposed to induce," says senior author Guido Silvestri, chief of microbiology and immunology at Yerkes National Primate Research Center.
A large part of the vaccine effort has been focused on developing vaccines that stimulate antiviral T cells.
T cells come in two main categories, defined by the molecules found on their surfaces.
CD8 is a marker for "killer" cells, while CD4 is a marker for "helper" cells. CD4+ T cells are known to be primary targets for HIV and SIV infection, while several studies have proposed that CD8+ T cells could be valuable in controlling infection.
"This study shows that if a vaccine induces high levels of activated CD4+ T cells in mucosal tissues, any potential protective effect of the vaccine may be hampered," he explains.
The study emphasizes the unique challenges that HIV poses in terms of vaccine development, and the importance of pursuing vaccine concepts and products that elicit strong antiviral immune responses without increasing the number of CD4+ T cells in the
Source: Medindia
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV
Advertisement
 AIDS and PregnancyThe Acquired immune deficiency syndrome is brought about by the deadly human immunodeficiency virus. In the USA alone an estimate of 120,000 - 160,000 women are HIV- infected. | Advertisement
|
Advertisement
Recommended Reading
Latest AIDS/HIV News
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
How can you prevent HIV while breastfeeding? A monthly vaginal ring containing the antiretroviral drug dapivirine safely prevents HIV infection while breastfeeding.
Union Minister of State for Health Bharti Pravin Pawar had said that the government is providing free lifelong antiretroviral (ARV) medicines for people living with HIV.
Dr. Korosi said the goal to end AIDS by 2030 is badly off track, as inequalities, discrimination, and disregard for human rights are hampering our progress.